Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy.

Bue M, Sou T, Okkels ASL, Hanberg P, Thorsted A, Friberg LE, Andersson TL, Öbrink-Hansen K, Christensen S.

Int J Infect Dis. 2020 Jan 21;92:133-140. doi: 10.1016/j.ijid.2020.01.010. [Epub ahead of print]

2.

Simultaneous Retrodialysis by Drug for Cefuroxime Using Meropenem as an Internal Standard-A Microdialysis Validation Study.

Hanberg P, Bue M, Öbrink-Hansen K, Kabel J, Thomassen M, Tøttrup M, Søballe K, Stilling M.

J Pharm Sci. 2019 Nov 20. pii: S0022-3549(19)30757-9. doi: 10.1016/j.xphs.2019.11.014. [Epub ahead of print]

PMID:
31756324
3.

Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment.

Hanberg P, Öbrink-Hansen K, Thorsted A, Bue M, Tøttrup M, Friberg LE, Hardlei TF, Søballe K, Gjedsted J.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02390-17. doi: 10.1128/AAC.02390-17. Print 2018 May.

4.

Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?

Andersen MG, Thorsted A, Storgaard M, Kristoffersson AN, Friberg LE, Öbrink-Hansen K.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02306-17. doi: 10.1128/AAC.02306-17. Print 2018 May.

5.

Penicillin G Treatment in Infective Endocarditis Patients - Does Standard Dosing Result in Therapeutic Plasma Concentrations?

Öbrink-Hansen K, Wiggers H, Bibby BM, Hardlei TF, Jensen K, Kragh Thomsen M, Brock B, Petersen E.

Basic Clin Pharmacol Toxicol. 2017 Feb;120(2):179-186. doi: 10.1111/bcpt.12661. Epub 2016 Sep 16.

6.

Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations.

Öbrink-Hansen K, Jensen-Fangel S, Brock B, Hardlei TF, Adelfred A, Nejatbakhsh Y, Kragh Thomsen M, Petersen E.

J Cyst Fibros. 2016 Mar;15(2):e13-4. doi: 10.1016/j.jcf.2015.10.005. Epub 2015 Oct 17. No abstract available.

7.

Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?

Öbrink-Hansen K, Juul RV, Storgaard M, Thomsen MK, Hardlei TF, Brock B, Kreilgaard M, Gjedsted J.

Antimicrob Agents Chemother. 2015 Nov;59(11):7018-26. doi: 10.1128/AAC.01347-15. Epub 2015 Sep 8.

8.

Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumonia.

Öbrink-Hansen K, Hardlei TF, Brock B, Jensen-Fangel S, Kragh Thomsen M, Petersen E, Kreilgaard M.

Antimicrob Agents Chemother. 2015 Apr;59(4):2398-404. doi: 10.1128/AAC.04659-14. Epub 2015 Feb 9.

9.

Risk factors for pneumococcal nasopharyngeal colonization before and after pneumococcal conjugate vaccination in persons with HIV: brief report.

Öbrink-Hansen K, Søgaard OS, Harboe ZB, Schønheyder HC.

Curr HIV Res. 2012 Apr;10(3):252-5.

PMID:
22384845
10.

[Tillaux fracture and fracture of the lateral malleolus with no medial soreness].

Obrink-Hansen K, Borris LC.

Ugeskr Laeger. 2011 Aug 22;173(34):2049-50. Danish.

PMID:
21867659

Supplemental Content

Loading ...
Support Center